中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (9): 1153-1161.doi: 10.12092/j.issn.1009-2501.2026.09.001
• 基础研究 • 下一篇
张鑫宇1(
), 温绍文1, 赵斐2, 吴丽丽1, 张炅璐1, 房泽海2, 刘红杰1,*(
)
收稿日期:2025-08-15
修回日期:2026-01-20
出版日期:2026-09-26
发布日期:2026-10-08
通讯作者:
刘红杰
E-mail:yxjcsbt@163.com;hongjie_liu@jnu.edu.cn
作者简介:张鑫宇,博士在读,从事中医脑病学研究。E-mail:基金资助:
Xinyu ZHANG1(
), Shaowen WEN1, Fei ZHAO2, Lili WU1, Jionglu ZHANG1, Zehai FANG2, Hongjie LIU1,*(
)
Received:2025-08-15
Revised:2026-01-20
Online:2026-09-26
Published:2026-10-08
Contact:
Hongjie LIU
E-mail:yxjcsbt@163.com;hongjie_liu@jnu.edu.cn
摘要:
目的: 探讨天麻及其主要活性成分天麻素对帕金森病的潜在治疗机制,重点分析其在细胞凋亡、氧化应激及磷脂酰肌醇-3-激酶(PI3K)/RAC丝氨酸/苏氨酸蛋白激酶(Akt)/丝氨酸/苏氨酸蛋白激酶mTOR(mTOR)信号通路中的作用。方法: 采用 6-羟基多巴胺(6-OHDA)诱导的PC12细胞损伤模型,通过体外实验评估天麻素对细胞凋亡、细胞内活性氧水平及PI3K/Akt/mTOR信号通路相关蛋白表达的影响。结果: 实验结果表明,天麻素可显著改善6-OHDA诱导的PC12细胞凋亡,并对PI3K信号通路活性产生调控作用。此外,天麻素能够有效降低细胞内活性氧水平,该作用不依赖于PI3K信号通路的调控。结论: 天麻素可能通过降低细胞内活性氧水平并调控 PI3K/Akt/mTOR 信号通路的活性,协同发挥神经保护作用,从而减轻6-OHDA诱导的细胞凋亡,为其在帕金森病防治中的应用提供实验依据。
中图分类号:
张鑫宇, 温绍文, 赵斐, 吴丽丽, 张炅璐, 房泽海, 刘红杰. 天麻素通过调控PI3K信号通路并降低活性氧水平减轻6-羟基多巴胺诱导的PC12细胞凋亡[J]. 中国临床药理学与治疗学, 2026, 31(9): 1153-1161.
Xinyu ZHANG, Shaowen WEN, Fei ZHAO, Lili WU, Jionglu ZHANG, Zehai FANG, Hongjie LIU. Gastrodin attenuates 6-hydroxydopamine-induced apoptosis in PC12 cells by modulating the PI3K signaling pathway and reducing reactive oxygen species levels[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(9): 1153-1161.
图 1
Fig.1 Effect of gastrodin on apoptosis of PC12 cells A: cell viability of PC12 cells treated with different concentrations of 6-OHDA. B: cell viability of PC12 cells treated with different concentrations of gastrodin (GSD). C: effects of gastrodin at different concentrations on the viability of PC12 cells exposed to 60 μmol/L 6-OHDA. Cell viability in panels (A–C) was assessed using the MTT assay. D–E: flow cytometric analysis of apoptosis. F: Western blot analysis of Bax, BCL-2, and Caspase-3 protein expression in PC12 cells. G–I: quantitative analysis of Bax, BCL-2, and Caspase-3 protein levels. Protein bands were quantified by densitometric analysis and normalized to GAPDH. Data are presented as mean±SEM. For panels (A–C), n=5–6; for panels (F–I), n=3. *P<0.05, **P<0.01, ***P<0.001.
图 2
Fig.2 Effects of gastrodin on apoptosis of PC12 cells while adding LY294002 A–B: representative flow cytometric analysis of cell apoptosis. Data are presented as mean±SEM, n=3. ***P<0.001.
图 3
Fig.3 Effects of gastrodin on Bax, BCL-2 and Caspase-3 protein expression of PC12 cells while adding LY294002 A: Western blot analysis of Bax, BCL-2, and Caspase-3 protein expression in PC12 cells. B–D: quantitative analysis of Bax, BCL-2, and Caspase-3 protein levels. Protein bands were quantified by densitometric analysis and normalized to GAPDH. Data are presented as mean±SEM, n=3. **P<0.01, ***P<0.001.
图 4
Fig.4 Effect of gastrodin on the protein expression of PI3K, Akt and mTOR A: Western blot analysis of PI3K, Akt, and mTOR protein expression in PC12 cells. B–D: quantitative analysis of PI3K, Akt, and mTOR protein levels. Protein bands were quantified by densitometric analysis and normalized to GAPDH. E–F: representative flow cytometric fluorescence intensity profiles. Data are presented as mean±SEM, n=3. ***P<0.001.
图 5
Fig.5 The level of ROS production under the intervention of gastrodin A: Western blot analysis of PI3K, Akt, and mTOR protein expression in PC12 cells. B–D: quantitative analysis of PI3K, Akt, and mTOR protein levels. Protein bands were quantified by densitometric analysis and normalized to GAPDH. Data are presented as mean±SEM, n=3. *P<0.05, **P<0.01, ***P<0.001.
| 1 |
Abbas MM, Xu Z, Tan LCS. Epidemiology of Parkinson's disease-east versus west[J]. Mov Disord Clin Pract, 2018, 5 (1): 14- 28.
doi: 10.1002/mdc3.12568 |
| 2 |
Collaborators GN. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol, 2019, 18 (5): 459- 480.
doi: 10.1016/S1474-4422(18)30499-X |
| 3 |
Narkiewicz J, Giachin G, Legname G. In vitro aggregation assays for the characterization of α-synuclein prion-like properties[J]. Prion, 2014, 8 (1): 19- 32.
doi: 10.4161/pri.28125 |
| 4 |
Winklhofer KF, Haass C. Mitochondrial dysfunction in Parkinson's disease[J]. Biochim Biophys Acta, 2010, 1802 (1): 29- 44.
doi: 10.1016/j.bbadis.2009.08.013 |
| 5 | Wright R. Mitochondrial dysfunction and Parkinson's disease[J]. Nat Neurosci, 2022, 25 (1): 2. |
| 6 |
刘娟, 李彦杰, 秦合伟, 等. 线粒体质量控制系统失调介导帕金森病的作用机制[J]. 实用医学杂志, 2024, 40 (11): 1479- 1482.
doi: 10.3969/j.issn.1006-5725.2024.11.002 |
| 7 | Meredith GE, Totterdell S, Potashkin JA, et al. Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol [J]. Parkinsonism Relat Disord, 2008, 14 Suppl 2(Suppl 2): S112-S115. |
| 8 |
Kalyanaraman B, Cheng G, Hardy M. Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: relevance to Parkinson's disease and therapeutic implications[J]. Redox Biol, 2024, 71, 103092.
doi: 10.1016/j.redox.2024.103092 |
| 9 |
Schwienbacher C, Foco L, Picard A, et al. Plasma and white blood cells show different miRNA expression profiles in Parkinson's disease[J]. J Mol Neurosci, 2017, 62 (2): 244- 254.
doi: 10.1007/s12031-017-0926-9 |
| 10 |
Poewe W, Seppi K, Tanner CM, et al. Parkinson disease[J]. Nat Rev Dis Primers, 2017, 3, 17013.
doi: 10.1038/nrdp.2017.13 |
| 11 | Guo QQ, Wang SS, Jiang XY, et al. Mitochondrial ROS triggers mitophagy through activating the DNA damage response signaling pathway [J]. Proc Natl Acad Sci U S A, 2025, 122(40): e2502841122. |
| 12 |
Chou KL, Stacy M, Simuni T, et al. The spectrum of "off" in Parkinson's disease: What have we learned over 40 years ?[J]. Parkinsonism Relat Disord, 2018, 51, 9- 16.
doi: 10.1016/j.parkreldis.2018.02.001 |
| 13 |
Zhang G, Xiong N, Zhang Z, et al. Effectiveness of traditional Chinese medicine as an adjunct therapy for Parkinson's disease: a systematic review and meta-analysis[J]. PLoS One, 2015, 10 (3): e0118498.
doi: 10.1371/journal.pone.0118498 |
| 14 |
韩欣园, 刘翼骁, 肖依彤, 等. 中药多糖治疗帕金森病的研究进展[J]. 中华神经医学杂志, 2025, 24 (5): 524- 31.
doi: 10.3760/cma.j.cn115354-20241226-00810 |
| 15 |
Leite Silva ABR, Gonçalves De Oliveira RW, Diógenes GP, et al. Premotor, nonmotor and motor symptoms of Parkinson's disease: a new clinical state of the art[J]. Ageing Res Rev, 2023, 84, 101834.
doi: 10.1016/j.arr.2022.101834 |
| 16 | 姬之翼, 刘鸿高, 李杰庆, 等. 天麻化学成分、药理活性及质量标志物研究进展 [J]. 特产研究, 2025: 1-12. |
| 17 | 中华人民共和国药典 2020版 [M]. 北京: 中国医药科技出版社, 2020. |
| 18 |
杨飞, 王信, 马传江, 等. 天麻加工炮制、成分分析与体内代谢研究进展[J]. 中国中药杂志, 2018, 43 (11): 2207- 2215.
doi: 10.19540/j.cnki.cjcmm.20180322.008 |
| 19 |
Xia C, Zhou H, Xu X, et al. Identification and investigation of miRNAs from gastrodia elata blume and their potential function[J]. Front Pharmacol, 2020, 11, 542405.
doi: 10.3389/fphar.2020.542405 |
| 20 |
Dai Y, Ban W, Yang Z. Gastrodin, a promising natural small molecule for the treatment of central nervous system disorders, and its recent progress in synthesis, pharmacology and pharmacokinetics[J]. Int J Mol Sci, 2024, 25 (17): 9540.
doi: 10.3390/ijms25179540 |
| 21 |
He X, Chen X, Yang Y, et al. The role of gastrodin in the management of CNS-related diseases: underlying mechanisms to therapeutic perspectives[J]. Phytother Res, 2024, 38 (11): 5107- 5133.
doi: 10.1002/ptr.8314 |
| 22 |
Luo S, Kang SS, Wang ZH, et al. Akt phosphorylates NQO1 and triggers its degradation, abolishing its antioxidative activities in Parkinson's disease[J]. J Neurosci, 2019, 39 (37): 7291- 7305.
doi: 10.1523/JNEUROSCI.0625-19.2019 |
| 23 |
Payne JM, Haebich KM, Mitchell R, et al. Brain volumes in genetic syndromes associated with mTOR dysregulation: a systematic review and meta-analysis[J]. Mol Psychiatry, 2025, 30 (4): 1676- 1688.
doi: 10.1038/s41380-024-02863-4 |
| 24 | 张炅璐. 天麻活性成分治疗帕金森病作用机制的网络药理学预测及实验研究 [D]. 广州: 暨南大学, 2021. |
| 25 |
Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030[J]. Neurology, 2007, 68 (5): 384- 386.
doi: 10.1212/01.wnl.0000247740.47667.03 |
| 26 | Liu HJ, He TZ, Zhang JL, et al. [Systematic review and screening of basic Chinese herbs for traditional Chinese medicine compounds combined with levodopa medicine in treatment of Parkinson's disease][J]. Zhongguo Zhong Yao Za Zhi, 2020, 45 (24): 6043- 6052. |
| 27 |
Chun YS, Kim J, Chung S, et al. Protective roles of monsonia angustifolia and its active compounds in experimental models of Alzheimer's disease[J]. J Agric Food Chem, 2017, 65 (15): 3133- 3140.
doi: 10.1021/acs.jafc.6b04451 |
| 28 |
Ogut E, Armagan K, Gül Z. The role of syringic acid as a neuroprotective agent for neurodegenerative disorders and future expectations[J]. Metab Brain Dis, 2022, 37 (4): 859- 880.
doi: 10.1007/s11011-022-00960-3 |
| 29 |
Kim IS, Choi DK, Jung HJ. Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells[J]. Molecules, 2011, 16 (7): 5349- 5361.
doi: 10.3390/molecules16075349 |
| 30 |
Hu D, Qing G, Liu X, et al. A study and in vitro evaluation of the bioactive compounds of broad bean sprouts for the treatment of Parkinson's syndrome[J]. Molecules, 2024, 29 (21): 5107.
doi: 10.3390/molecules29215107 |
| 31 | Xiao G, Tang R, Yang N, et al. Review on pharmacological effects of gastrodin[J]. Arch Pharm Res, 2023, 46 (9/10): 744- 770. |
| 32 |
Guo H, Li C, Zhao J, et al. Mechanism of gastrodin against neurotoxicity based on network pharmacology, molecular docking and experimental verification[J]. Biomed Pharmacother, 2024, 180, 117611.
doi: 10.1016/j.biopha.2024.117611 |
| 33 |
Zhan HD, Zhou HY, Sui YP, et al. The rhizome of Gastrodia elata Blume-An ethnopharmacological review[J]. J Ethnopharmacol, 2016, 189, 361- 385.
doi: 10.1016/j.jep.2016.06.057 |
| 34 |
Liao W, Dong A, Hafeez F, et al. Celastrol protected the MPTP-injected mice Parkinson's disease model via redox regulation of CDC37[J]. Phytomedicine, 2025, 145, 157067.
doi: 10.1016/j.phymed.2025.157067 |
| 35 |
Yuan J, Ofengeim D. A guide to cell death pathways[J]. Nat Rev Mol Cell Biol, 2024, 25 (5): 379- 395.
doi: 10.1038/s41580-023-00689-6 |
| 36 |
Czabotar PE, Garcia-saez AJ. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis[J]. Nat Rev Mol Cell Biol, 2023, 24 (10): 732- 748.
doi: 10.1038/s41580-023-00629-4 |
| 37 |
Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins[J]. Nat Rev Mol Cell Biol, 2019, 20 (3): 175- 193.
doi: 10.1038/s41580-018-0089-8 |
| 38 |
Kaur S, Sehrawat A, Mastana SS, et al. Targeting calcium homeostasis and impaired inter-organelle crosstalk as a potential therapeutic approach in Parkinson's disease[J]. Life Sci, 2023, 330, 121995.
doi: 10.1016/j.lfs.2023.121995 |
| 39 |
Nixon RA. Autophagy-lysosomal-associated neuronal death in neurodegenerative disease[J]. Acta Neuropathol, 2024, 148 (1): 42.
doi: 10.1007/s00401-024-02799-7 |
| 40 |
Yu L, Wei J, Liu P. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer[J]. Semin Cancer Biol, 2022, 85, 69- 94.
doi: 10.1016/j.semcancer.2021.06.019 |
| 41 |
Goyal A, Agrawal A, Verma A, et al. The PI3K-AKT pathway: a plausible therapeutic target in Parkinson's disease[J]. Exp Mol Pathol, 2023, 129, 104846.
doi: 10.1016/j.yexmp.2022.104846 |
| 42 |
Yang S, Lian G. ROS and diseases: role in metabolism and energy supply[J]. Mol Cell Biochem, 2020, 467 (1/2): 1- 12.
doi: 10.1007/s11010-019-03667-9 |
| 43 |
Song J, Wang Y, Yuan X, et al. Stretching magnitude-dependent inactivation of AKT by ROS led to enhanced p53 mitochondrial translocation and myoblast apoptosis[J]. Mol Biol Cell, 2019, 30 (10): 1182- 1197.
doi: 10.1091/mbc.E18-12-0770 |
| [1] | 王晓丽, 邵静, 张薇, 田萍, 张雪侠, 刘长河, 李开言, 杨丹, 郭晓燕. 基于自噬流及CXCL12/CXCR4轴研究天麻钩藤饮对肝阳上亢证脑缺血再灌注大鼠模型的神经保护作用及机制[J]. 中国临床药理学与治疗学, 2025, 30(8): 1037-1048. |
| [2] | 张建新, 杨孝来. 甘草苷抑制吗啡引起的神经损伤作用及机制[J]. 中国临床药理学与治疗学, 2024, 29(5): 554-560. |
| [3] | 刘敏, 丁艳霞, 张业贵, 产翠翠, 龚儒杰, 倪进忠. 天麻素对脑缺血大鼠纹状体BDNF、IL-6表达的影响[J]. 中国临床药理学与治疗学, 2024, 29(4): 440-446. |
| [4] | 黄小梅, 支慧, 陈浩, 卢林明, 朱晓群, 王丽珍, 周珏, 庞金金, 许金亮. 皖南蝮蛇毒抑瘤组分-Ⅰ对胃癌MKN-28细胞增殖、迁移及凋亡的影响[J]. 中国临床药理学与治疗学, 2024, 29(3): 270-276. |
| [5] | 庞丽丽, 胡莹, 罗洁, 涂勤, 陈岷. CA-4类衍生物LGD5诱导人宫颈癌HeLa细胞发生G2/M周期阻滞和凋亡的机制研究[J]. 中国临床药理学与治疗学, 2024, 29(10): 1100-1109. |
| [6] | 杨晓佳, 江 萌, 吴 敏, 张伊黎, 吕 兰, 吴嫄芬, 王鑫昱, 刘立权. 藏红花素介导DKK3调控GSK-3β/β-catenin通路对阿尔兹海默症大鼠的认知改善作用[J]. 中国临床药理学与治疗学, 2023, 28(5): 489-497. |
| [7] | 王 剑, 孙永东, 周兴玮, 刘 雷, 陈 龙, 童兴科, 朱佳丽. 黄芩素经由miR-125b-5p/IRF4轴进而促进喉癌细胞死亡并抑制其侵袭的机制研究[J]. 中国临床药理学与治疗学, 2023, 28(11): 1209-1218. |
| [8] | 华海燕, 严杰, 秦宇芬. 五味子乙素通过抑制心肌细胞凋亡减轻大鼠心肌缺血再灌注损伤的实验研究[J]. 中国临床药理学与治疗学, 2022, 27(8): 848-856. |
| [9] | 李雪恒, 李龙. 褪黑素与特发性肺纤维化关系的研究进展[J]. 中国临床药理学与治疗学, 2022, 27(6): 715-720. |
| [10] | 李莹, 姚伟, 王萌, 余志宏, 龚园其, 蓝海兵, 齐协飞. 鸢尾素通过NF-κB和JNK信号通路减轻屋尘螨诱导的气道上皮细胞炎症及凋亡的实验研究[J]. 中国临床药理学与治疗学, 2022, 27(10): 1106-1112. |
| [11] | 郭宇婷, 李珊珊, 李庆林. 天麻钩藤饮抑制铁死亡-脂质代谢保护鱼藤酮诱导的PC12细胞损伤[J]. 中国临床药理学与治疗学, 2022, 27(1): 8-14. |
| [12] | 刘云帆, 杜月梅, 刘晓艺, 高丽萍. 枸杞多糖对顺铂诱导小鼠睾丸支持细胞凋亡的影响[J]. 中国临床药理学与治疗学, 2021, 26(6): 624-630. |
| [13] | 王幼琳, 李珊珊, 王萌, 郭宇婷, 程卉, 田莎莎, 李庆林. 天麻素抑制H2O2诱导的PC12细胞铁死亡[J]. 中国临床药理学与治疗学, 2021, 26(5): 532-538. |
| [14] | 张伟萍, 江建军, 陈晓锋, 许莎莎. 栀子苷通过抑制VPO1/ERK1/2信号通路减轻糖尿病心肌病大鼠的心肌细胞凋亡[J]. 中国临床药理学与治疗学, 2021, 26(2): 129-136. |
| [15] | 吴畏, 李广鹏, 张江波, 孔令宇, 蔡君艳, 杨飞云. 天麻素联合地塞米松保护缺糖缺氧诱导的H9C2细胞损伤[J]. 中国临床药理学与治疗学, 2021, 26(11): 1244-1249. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||